中文 | English
Return

THE SIGNIFICANCE OF TREATMENT AND PROGNOSTIC EVALUATION OF TISSUE POLYPEPTIDE SPECIFIC ANTIGEN IN PATIENTS WITH HEPATOCELLULAR CARCINOMA